Your browser doesn't support javascript.
loading
Comparative Real Life Egyptian Experience of the Combination of Sofosbuvir Plus Daclatasvir or Simeprevir for 12 Weeks in Naïve Cirrhotic Patients Infected with HCV Genotype 4.
Ahmed, Sayed; Hassan, Essam; Gomaa, Ahmed; Esamat, Gamal; Ramadan, Ahmed; Ahmed, Manar; Elsayed, Aya; A Wahsh, Engy.
Afiliação
  • Ahmed S; Department of Tropical Medicine, Faculty of Medicine, Fayoum University, Fayoum 63511, Egypt.
  • Hassan E; Department of Tropical Medicine, Faculty of Medicine, Fayoum University, Fayoum 63511, Egypt.
  • Gomaa A; Department of Tropical Medicine, Faculty of Medicine, Fayoum University, Fayoum 63511, Egypt.
  • Esamat G; Department of Endemic Medicine, Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Ramadan A; Department of Endemic Medicine, Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Ahmed M; Department of Clinical Pharmacy, Faculty of Pharmacy, Beni Suef University, Beni Suef 62521, Egypt.
  • Elsayed A; Department of Clinical Pharmacy, Faculty of Pharmacy, October 6 University, Giza 12573, Egypt.
  • A Wahsh E; Department of Clinical Pharmacy, Faculty of Pharmacy, October 6 University, Giza 12573, Egypt.
Curr Drug Saf ; 18(2): 207-213, 2023.
Article em En | MEDLINE | ID: mdl-35538812

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 Base de dados: MEDLINE Assunto principal: Hepatite C Crônica / Sofosbuvir Limite: Humans País/Região como assunto: Africa Idioma: En Revista: Curr Drug Saf Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 Base de dados: MEDLINE Assunto principal: Hepatite C Crônica / Sofosbuvir Limite: Humans País/Região como assunto: Africa Idioma: En Revista: Curr Drug Saf Ano de publicação: 2023 Tipo de documento: Article